Back | Next |
home / stock / aqst / aqst message board
Subject | By | Source | When |
---|---|---|---|
J L: AQST - Update https://youtu.be/8-csI8G1e-8 | J L | investorshangout | 10/15/2021 7:06:04 PM |
$AQST - Tuesday Rundown, Wednesday Expectations | Jake L | investorshub | 09/08/2021 3:47:33 AM |
J L: AQST - Tuesday Rundown, Wednesday Expectations https://youtu.be/gEeUmBfdkMk | J L | investorshangout | 09/08/2021 3:45:19 AM |
$AQST - Update | Jake L | investorshub | 09/05/2021 11:28:20 PM |
$AQST - Thursday Rundown, Friday Expectations | Jake L | investorshub | 09/03/2021 5:40:40 AM |
$AQST - Update Morning Report | Jake L | investorshub | 09/02/2021 3:52:49 PM |
$AQST - Tuesday Rundown, Wednesday Expectations | Jake L | investorshub | 08/31/2021 10:37:35 PM |
$AQST - Morning Report | Jake L | investorshub | 08/31/2021 5:12:02 PM |
$AQST - Monday Morning Report | Jake L | investorshub | 08/30/2021 4:40:55 PM |
AQST - Monday's Plays Which will Short Squeeze | Jake L | investorshub | 08/30/2021 4:49:57 AM |
GREAT NEWS! | DorseyE | investorshub | 09/29/2020 6:33:04 PM |
Aquestive Therapeutics price target lowered to $7 from | realfast95 | investorshub | 09/28/2020 4:00:45 PM |
Way over raction-- I am buying | doc7 | investorshub | 09/26/2020 10:33:21 AM |
It looks like a minor fixable issue. | Aarin | investorshub | 09/26/2020 12:20:43 AM |
Aquestive Therapeutics Receives Complete Response Letter from FDA | realfast95 | investorshub | 09/25/2020 11:17:32 PM |
pipeline is great. | doc7 | investorshub | 09/17/2020 5:56:16 PM |
* * $AQST Video Chart 08-18-2020 * * | ClayTrader | investorshub | 08/18/2020 10:06:39 PM |
FAst Track designation PR | Amatuer17 | investorshub | 08/10/2020 12:00:55 PM |
Pretty good bounce today though | king oil | investorshub | 07/15/2020 7:44:42 PM |
12 down days in a row : ( | Aarin | investorshub | 07/14/2020 4:20:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Aquestive Therapeutics Inc. Company Name:
AQST Stock Symbol:
NASDAQ Market:
Aquestive Therapeutics Inc. Website:
WARREN, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...
Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pH Remains on track to complete Anaphylm supportive clinical studies and expects to request pre-NDA meeting with FDA in the third quarter 2024 Continues to anticipate filin...
WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...